Your browser doesn't support javascript.
loading
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.
Apostolidis, Leonidas; Lang, Kristin; Sisic, Leila; Busch, Elena; Ahadova, Aysel; Wullenkord, Ramona; Nienhüser, Henrik; Billeter, Adrian; Müller-Stich, Beat; Kloor, Matthias; Jaeger, Dirk; Haag, Georg Martin.
Affiliation
  • Apostolidis L; National Center for Tumor Diseases (NCT) Heidelberg, Department of Medical Oncology, Heidelberg University Hospital, Im Neuenheimer Feld, 460, 69120, Heidelberg, Germany.
  • Lang K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sisic L; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Busch E; National Center for Tumor Diseases (NCT) Heidelberg, Department of Medical Oncology, Heidelberg University Hospital, Im Neuenheimer Feld, 460, 69120, Heidelberg, Germany.
  • Ahadova A; Department of Applied Tumor Biology, University Hospital Heidelberg, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Wullenkord R; National Center for Tumor Diseases (NCT) Heidelberg, Department of Medical Oncology, Heidelberg University Hospital, Im Neuenheimer Feld, 460, 69120, Heidelberg, Germany.
  • Nienhüser H; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Billeter A; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller-Stich B; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Kloor M; Department of Applied Tumor Biology, University Hospital Heidelberg, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Jaeger D; National Center for Tumor Diseases (NCT) Heidelberg, Department of Medical Oncology, Heidelberg University Hospital, Im Neuenheimer Feld, 460, 69120, Heidelberg, Germany.
  • Haag GM; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
J Cancer Res Clin Oncol ; 149(4): 1373-1382, 2023 Apr.
Article in En | MEDLINE | ID: mdl-35441345
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: